The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy
- PMID: 21922905
The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy
Abstract
Berberis darwinii is native to South America but has been widely distributed in Europe and other continents following its discovery by Charles Darwin. Herewith, the therapeutic potential of stem-bark of the plant for treating Alzheimer's disease was studied using an in vitro acetylcholinesterase inhibition assay. It was found that the methanolic extract of the stem-bark was a potent inhibitor of the enzyme with an IC50 value of 1.23 +/- 0.05 microg/mL. An HPLC-based berberine quantification study revealed an astonishing 38% yield of the dried methanolic extract.
Similar articles
-
Habitat-dependent variations in berberine content of Berberis asiatica Roxb. ex. DC. in Kumaon, Western Himalaya.Chem Biodivers. 2010 Feb;7(2):415-20. doi: 10.1002/cbdv.200900041. Chem Biodivers. 2010. PMID: 20151388
-
[Determination of four alkaloids in Berberis plants by HPLC].Zhongguo Zhong Yao Za Zhi. 2003 Dec;28(12):1132-4. Zhongguo Zhong Yao Za Zhi. 2003. PMID: 15617491 Chinese.
-
[Distribution of four alkaloids in plants of Berberis].Zhong Yao Cai. 2004 Feb;27(2):83-6. Zhong Yao Cai. 2004. PMID: 22454993 Chinese.
-
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.Phytother Res. 2008 Aug;22(8):999-1012. doi: 10.1002/ptr.2399. Phytother Res. 2008. PMID: 18618524 Review.
-
Berberine and barberry (Berberis vulgaris): A clinical review.Phytother Res. 2019 Mar;33(3):504-523. doi: 10.1002/ptr.6252. Epub 2019 Jan 13. Phytother Res. 2019. PMID: 30637820 Review.
Cited by
-
Addressing the preventive and therapeutic perspective of berberine against diabetes.Heliyon. 2023 Nov 3;9(11):e21233. doi: 10.1016/j.heliyon.2023.e21233. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027723 Free PMC article. Review.
-
Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2022 Nov 18;13:1074348. doi: 10.3389/fendo.2022.1074348. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36465656 Free PMC article. Review.
-
Stem Cells and Natural Agents in the Management of Neurodegenerative Diseases: A New Approach.Neurochem Res. 2023 Jan;48(1):39-53. doi: 10.1007/s11064-022-03746-2. Epub 2022 Sep 16. Neurochem Res. 2023. PMID: 36112254 Review.
-
Berberine as a Potential Agent for the Treatment of Colorectal Cancer.Front Med (Lausanne). 2022 Apr 28;9:886996. doi: 10.3389/fmed.2022.886996. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572960 Free PMC article. Review.
-
The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches.Biomedicines. 2020 Apr 18;8(4):90. doi: 10.3390/biomedicines8040090. Biomedicines. 2020. PMID: 32325761 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical